Academic Journals Database
Disseminating quality controlled scientific knowledge

Cervix Cancer in a Patient With Ankylosing Spondylitis Using Etanercept: A Case Report

ADD TO MY LIST
 
Author(s): Pınar Doruk | Mehmet Adam | Berrin Leblebici

Journal: Türkiye Fiziksel Tip ve Rehabilitasyon Dergisi
ISSN 1302-0234

Volume: 58;
Issue: 2;
Start page: 162;
Date: 2012;
Original page

Keywords: Ankylosing spondylitis | etanercept | cervix cancer

ABSTRACT
Tumor necrosis factor-alpha inhibitors (anti TNF-alpha) are agents that increasingly used in the treatment of ankylosing spondylitis resistant to classical disease-modifying treatment and they provide better functional outcome. However, these agents have serious side effects. Their safety has been questioned by several published reports of increased risk for malignancies. In this study, we present a patient with ankylosing spondylitis who developed cervix cancer after receiving anti TNF-alpha therapy for 19 months. Turk J Phys Med Re­hab 2012;58:162-4.
Why do you need a reservation system?      Save time & money - Smart Internet Solutions